PFM Health Sciences as of Sept. 30, 2022
Portfolio Holdings for PFM Health Sciences
PFM Health Sciences holds 81 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cytokinetics Com New (CYTK) | 4.3 | $119M | 2.5M | 48.45 | |
| BioMarin Pharmaceutical Call Option (BMRN) | 4.0 | $110M | 1.3M | 84.77 | |
| Penumbra Call Option (PEN) | 3.9 | $108M | 568k | 189.60 | |
| Eli Lilly & Co. (LLY) | 3.5 | $97M | 299k | 323.35 | |
| Arcus Biosciences Incorporated (RCUS) | 3.2 | $89M | 3.4M | 26.16 | |
| Centene Corporation (CNC) | 3.1 | $87M | 1.1M | 77.81 | |
| Biogen Idec Call Option (BIIB) | 3.0 | $82M | 306k | 267.00 | |
| Humana (HUM) | 2.9 | $81M | 166k | 485.19 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.8 | $76M | 572k | 133.29 | |
| Axsome Therapeutics (AXSM) | 2.7 | $74M | 1.7M | 44.62 | |
| Horizon Therapeutics Pub L SHS | 2.4 | $68M | 1.1M | 61.89 | |
| Caribou Biosciences (CRBU) | 2.3 | $63M | 6.0M | 10.55 | |
| Irhythm Technologies (IRTC) | 2.2 | $62M | 494k | 125.28 | |
| Erasca (ERAS) | 2.1 | $57M | 7.3M | 7.80 | |
| UnitedHealth (UNH) | 2.0 | $56M | 112k | 505.04 | |
| Prothena Corp SHS Call Option (PRTA) | 2.0 | $56M | 921k | 60.63 | |
| Seagen | 1.8 | $50M | 365k | 136.83 | |
| Oak Str Health Note 3/1 (Principal) | 1.8 | $49M | 63M | 0.78 | |
| Molina Healthcare (MOH) | 1.7 | $47M | 144k | 329.84 | |
| Aerie Pharmaceuticals Note 1.500%10/0 (Principal) | 1.7 | $47M | 48M | 0.98 | |
| Biomarin Pharmaceutical Note 0.599% 8/0 (Principal) | 1.6 | $46M | 46M | 0.99 | |
| Select Sector Spdr Tr Technology Put Option (XLK) | 1.6 | $46M | 384k | 118.78 | |
| Danaher Corporation (DHR) | 1.6 | $45M | 176k | 258.29 | |
| Uniqure Nv SHS (QURE) | 1.6 | $45M | 2.4M | 18.76 | |
| Cardinal Health (CAH) | 1.5 | $43M | 640k | 66.68 | |
| Abbvie (ABBV) | 1.5 | $43M | 317k | 134.21 | |
| Iqvia Holdings (IQV) | 1.5 | $42M | 229k | 181.14 | |
| Avantor (AVTR) | 1.5 | $41M | 2.1M | 19.60 | |
| Verve Therapeutics (VERV) | 1.5 | $40M | 1.2M | 34.35 | |
| Dynavax Technologies Corp Com New (DVAX) | 1.4 | $40M | 3.8M | 10.44 | |
| Edwards Lifesciences (EW) | 1.4 | $40M | 480k | 82.63 | |
| Cigna Corp (CI) | 1.4 | $39M | 141k | 277.47 | |
| Argenx Se Sponsored Adr (ARGX) | 1.3 | $37M | 105k | 353.05 | |
| McKesson Corporation (MCK) | 1.3 | $36M | 106k | 339.87 | |
| Point Biopharma Global | 1.3 | $35M | 4.5M | 7.73 | |
| Veeva Sys Cl A Com (VEEV) | 1.2 | $33M | 202k | 164.88 | |
| Hca Holdings (HCA) | 1.2 | $32M | 175k | 183.79 | |
| Waters Corporation (WAT) | 1.1 | $32M | 118k | 269.53 | |
| Astrazeneca Sponsored Adr (AZN) | 1.1 | $32M | 577k | 54.84 | |
| Thermo Fisher Scientific (TMO) | 1.1 | $32M | 62k | 507.19 | |
| Merck & Co (MRK) | 1.1 | $31M | 361k | 86.12 | |
| Syndax Pharmaceuticals (SNDX) | 1.1 | $31M | 1.3M | 24.03 | |
| Karuna Therapeutics Ord | 1.1 | $29M | 130k | 224.93 | |
| Tenet Healthcare Corp Com New (THC) | 1.0 | $28M | 545k | 51.58 | |
| BioCryst Pharmaceuticals (BCRX) | 1.0 | $27M | 2.2M | 12.60 | |
| Nevro (NVRO) | 1.0 | $26M | 564k | 46.60 | |
| Icon SHS (ICLR) | 0.9 | $25M | 135k | 183.78 | |
| ICU Medical, Incorporated (ICUI) | 0.9 | $24M | 160k | 150.60 | |
| Johnson & Johnson (JNJ) | 0.8 | $23M | 138k | 163.36 | |
| Procept Biorobotics Corp (PRCT) | 0.8 | $22M | 518k | 41.46 | |
| Intellia Therapeutics (NTLA) | 0.7 | $19M | 345k | 55.96 | |
| Oak Street Health | 0.6 | $18M | 723k | 24.52 | |
| Generation Bio (GBIO) | 0.6 | $16M | 3.0M | 5.31 | |
| Editas Medicine (EDIT) | 0.6 | $16M | 1.3M | 12.24 | |
| Myriad Genetics (MYGN) | 0.5 | $14M | 742k | 19.08 | |
| Werewolf Therapeutics (HOWL) | 0.5 | $13M | 2.8M | 4.51 | |
| Anthem (ELV) | 0.4 | $12M | 26k | 454.22 | |
| Outset Med (OM) | 0.4 | $12M | 729k | 15.93 | |
| Iteos Therapeutics (ITOS) | 0.4 | $10M | 538k | 19.05 | |
| Pmv Pharmaceuticals (PMVP) | 0.4 | $10M | 855k | 11.90 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.4 | $10M | 9.3M | 1.07 | |
| Jounce Therapeutics | 0.3 | $9.6M | 4.1M | 2.34 | |
| Blueprint Medicines (BPMC) | 0.3 | $8.6M | 130k | 65.89 | |
| Nevro Corp Note 2.750% 4/0 (Principal) | 0.3 | $8.5M | 9.0M | 0.95 | |
| Apellis Pharmaceuticals (APLS) | 0.3 | $8.3M | 122k | 68.30 | |
| Praxis Precision Medicines I | 0.3 | $7.9M | 3.5M | 2.27 | |
| Cano Health Com Cl A | 0.2 | $6.7M | 777k | 8.67 | |
| Dynavax Technologies Corp Note 2.500% 5/1 (Principal) | 0.2 | $6.3M | 5.0M | 1.27 | |
| Io Biotech (IOBT) | 0.2 | $5.9M | 2.2M | 2.71 | |
| Bcls Acquisition Corp Com Cl A | 0.2 | $4.6M | 464k | 10.02 | |
| Jiya Acquisition Corp Com Cl A | 0.2 | $4.6M | 464k | 9.97 | |
| Iveric Bio | 0.2 | $4.6M | 256k | 17.94 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.2 | $4.3M | 398k | 10.73 | |
| Sana Biotechnology (SANA) | 0.2 | $4.1M | 692k | 6.00 | |
| Pulmonx Corp (LUNG) | 0.1 | $3.3M | 200k | 16.66 | |
| Essa Pharma Com New (EPIX) | 0.1 | $2.7M | 1.5M | 1.82 | |
| Sophia Genetics Sa Ordinary Shares (SOPH) | 0.1 | $2.3M | 880k | 2.63 | |
| Sight Sciences (SGHT) | 0.1 | $1.4M | 228k | 6.35 | |
| Celcuity (CELC) | 0.1 | $1.4M | 140k | 10.04 | |
| Zai Lab Adr (ZLAB) | 0.0 | $808k | 24k | 34.22 | |
| Pardes Biosciences | 0.0 | $528k | 285k | 1.85 |
